ESR1 and breast carcinoma: In addition to ER-agonist, this phytoconstituent was known as AHR-antagonist (aryl hydrocarbon receptor), which was related to the inhibition activity on transcription of AHR in ER-α-negative breast cancer cell lines independent of ER-α expression [45].